what is glp-1 for weight loss Injections Chronic Pain GLP-1 and health: Beyond weight

Obese subjects receiving AOD-9604 by oral administration did not lose significantly more weight than those receiving placebo over 24 weeks

However, significant changes in exposure were observed for oral contraceptives and levothyroxine following the administration of tirzepatide and oral semaglutide, respectively, indicating the need for close monitoring in these instances

For example, downregulation of glucose transport protein GLUT1 and efflux transporters P-glycoprotein and LRP-1 contribute to nutrient starvation and buildup of metabolic waste products (Van Dyken and Lacoste, 2018

Its also possible to feel a bit restless or tired, particularly if DSIP is taken too close to bedtime